BioLoomics
Michael is a professor at the University of Colorado, Boulder in the Department of Molecular, Cellular, and Developmental Biology. He is a biophysicist with expertise in the structural biology of channels and receptors. He is a co-founder of InRedox and a co-founder and CSO of AmideBio. Michael joined the BioLoomics Scientific Advisory Board in 2021 and helps guide the decisions in performing targeted saturation mutagenesis of protein drugs to enhance specificity and efficacy.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
BioLoomics
BioLoomics, Inc. is a synthetic biology company building the next generation of high-throughput drug screening tools.